Powder: -20°C for 3 years | In solvent: -80°C for 1 year
THR-β agonist 2 is a potent agonist of THR-β. THR-β agonist 2 has potential for studies of metabolic diseases (e.g. obesity, hyperlipidaemia, hypercholesterolaemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,140.00 | |
50 mg | 6-8 weeks | $ 2,785.00 | |
100 mg | 6-8 weeks | $ 3,520.00 |
Description | THR-β agonist 2 is a potent agonist of THR-β. THR-β agonist 2 has potential for studies of metabolic diseases (e.g. obesity, hyperlipidaemia, hypercholesterolaemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases). |
Molecular Weight | 443.2 |
Formula | C18H8Cl2N6O4 |
CAS No. | 2440027-77-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
THR-β agonist 2 2440027-77-8 inhibitor inhibit